Provided By GlobeNewswire
Last update: Aug 8, 2025
FDA grants meeting for AVERSA™ FENTANYL (abuse deterrent transdermal system) to provide feedback on the Chemistry, Manufacturing, and Controls plans for the product through commercialization.
Read more at globenewswire.com1.523
+0.22 (+17.15%)
NASDAQ:NTRB (8/28/2025, 1:53:34 PM)
6.48
+0.07 (+1.09%)
Find more stocks in the Stock Screener